Emara M A, Mozes M F
Department of Surgery, Henry Ford Hospital, Detroit, Michigan 48202-2689, USA.
Hum Immunol. 1995 Feb;42(2):161-73. doi: 10.1016/0198-8859(94)00077-4.
We previously investigated the characteristics of renal allograft infiltrating T-cell lines that were propagated from biopsy and nephrectomy specimens designated as IG-Bip and IG-Neph, respectively, or analogous line designated IG-T-eff, which was generated by co-culturing pretransplant recipient blood with irradiated donor splenocytes (manuscript submitted). The recipient (IG) had no previous sensitization to donor mismatched HLA antigens (A2 and DR1). Phenotypically, all lines were of recipient origin and were CD3+, TCR alpha beta +, DR+. However IG-Bip line was low in CD4 (19%) and high in CD8 (50%), whereas IG-Neph and IG-T-eff lines had equal mixture of CD4+ (34%) and CD8+ (38%) subsets). Functionally, all three lines contained donor-specific CTLs. In the present report, we used the in vitro MLR to examine the possible utilization of these CTL lines as inducer cells to generate donor-specific Ts cells from recipient PBLs. Coculturing IG-PBL that was drawn before or after transplantation and immunosuppression with irradiated IG-T-eff or IG-Neph but not IG-Bip CTL lines, generated Ts cells. Ts cells were of recipient origin and were CD3+, CD8+, leu 11b+, CD28-, all characteristic of Ts-effector phenotype. Ts cells inhibited MLR response of recipient PBLs against donor or third-party stimulators that shared with the donor the mismatched HLA antigens. Ts suppression was more pronounced against early phase of MLR response and was not due to a shift in MLR kinetics or nonspecific soluble suppressor or cytotoxic products. These findings suggest that allograft infiltrating CTLs or their in vitro generated analogous line may modulate allograft rejection by acting as Ts inducers and that Ts induction was dependent on the presence of the CD4 subset within the Ts-inducer cells but was not dependent on renal transplantation or immunosuppression.
我们之前研究了从活检和肾切除标本中分别培养出的肾移植浸润性T细胞系的特征,这些标本分别命名为IG-Bip和IG-Neph,或者类似的命名为IG-T-eff的细胞系,后者是通过将移植前受者血液与经照射的供者脾细胞共培养产生的(稿件已提交)。受者(IG)之前对供者不匹配的HLA抗原(A2和DR1)没有致敏。从表型上看,所有细胞系均来自受者,为CD3+、TCRαβ+、DR+。然而,IG-Bip细胞系的CD4较低(19%),CD8较高(50%),而IG-Neph和IG-T-eff细胞系的CD4+(34%)和CD8+(38%)亚群混合比例相等。在功能上,所有这三个细胞系都含有供者特异性CTL。在本报告中,我们使用体外混合淋巴细胞反应来检测这些CTL细胞系作为诱导细胞从受者外周血淋巴细胞(PBL)中产生供者特异性调节性T细胞(Ts细胞)的可能性。将移植前或移植及免疫抑制后抽取的IG-PBL与经照射的IG-T-eff或IG-Neph而非IG-Bip CTL细胞系共培养,可产生Ts细胞。Ts细胞来自受者,为CD3+、CD8+、leu 11b+、CD28-,这些都是Ts效应细胞表型的特征。Ts细胞抑制了受者PBL对与供者共享不匹配HLA抗原的供者或第三方刺激物的混合淋巴细胞反应。Ts抑制在混合淋巴细胞反应的早期阶段更为明显,且不是由于混合淋巴细胞反应动力学的改变或非特异性可溶性抑制物或细胞毒性产物所致。这些发现表明,移植浸润性CTL或其体外产生的类似细胞系可能通过作为Ts诱导物来调节移植排斥反应,并且Ts诱导依赖于Ts诱导细胞中CD4亚群的存在,但不依赖于肾移植或免疫抑制。